F901318 - A Phase I, Double-Blind, Placebo Controlled, Single Ascending Oral Dose, Safety, Tolerability and Pharmacokinetic Study in Healthy Male Subjects

Trial Profile

F901318 - A Phase I, Double-Blind, Placebo Controlled, Single Ascending Oral Dose, Safety, Tolerability and Pharmacokinetic Study in Healthy Male Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Sep 2016

At a glance

  • Drugs F 901318 (Primary)
  • Indications Aspergillosis
  • Focus Adverse reactions
  • Sponsors F2G
  • Most Recent Events

    • 16 Sep 2016 Status changed from recruiting to completed.
    • 08 Aug 2016 Planned End Date changed from 1 Apr 2016 to 1 Dec 2016.
    • 08 Aug 2016 Planned primary completion date changed from 1 Apr 2016 to 1 Sep 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top